Williams & Novak’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Hold
45,000
0.09% 112
2025
Q1
$56.9K Hold
45,000
0.06% 114
2024
Q4
$77.9K Hold
45,000
0.08% 119
2024
Q3
$90.5K Hold
45,000
0.08% 118
2024
Q2
$101K Hold
45,000
0.09% 114
2024
Q1
$79.7K Hold
45,000
0.09% 85
2023
Q4
$79.7K Buy
+45,000
New +$79.7K 0.09% 85